Funding Rounds
OMass Technologies

OMass Technologies Series B (2023, $12M)

OMass Technologies

Clinical-stage drug discovery company.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $12.48M